Anaveon AG

Founded in 2017 by leading experts in the field of immunotherapy, Anaveon is a biopharmaceutical company that specializes in the development of treatments for diseases with immune system dysfunction. We are a group of motivated immunologists committed to delivering the power of cytokines to patients. Our goal is to harness the power of engineered cytokines and develop novel treatments for diseases with high unmet need. Anaveon is a clinical stage company committed to transforming immunological insights into life-saving therapies. With a vision to use our expertise in cutting-edge immunology to design and develop treatments that benefit patients and society, the team has the skills to make it happen and is ready to see the impact of ANV419 in patients.